Skip to main content
Clinical Trials/NCT02922153
NCT02922153
Completed
N/A

The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)

AtriCure, Inc.5 sites in 1 country84 target enrollmentJune 13, 2016

Overview

Phase
N/A
Intervention
Cryoanalgesia
Conditions
Pain
Sponsor
AtriCure, Inc.
Enrollment
84
Locations
5
Primary Endpoint
Primary Outcome 1: Forced Expiratory Volume (FEV1) at 48-Hours Post-Surgery
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The investigators propose to assess whether intra-operative intercostal cryoanalgesia using the cryoICE® probe (AtriCure®, Inc., 7555 Innovation Way, Mason, Ohio) provides superior post-operative analgesic efficacy as compared to current pain management in patients undergoing unilateral thoracotomy cardiac procedures.

Detailed Description

Completion of the proposed study will for the first time demonstrate efficacy of intercostal cryoanalgesia in patients undergoing minimally invasive cardiac procedures. Furthermore, results of this study may have a pivotal role in supporting future clinical outcome trials for intercostal cryoanalgesia therapy.

Registry
clinicaltrials.gov
Start Date
June 13, 2016
End Date
August 28, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18 - 85 years male or female
  • Patients undergoing unilateral thoracotomy cardiac procedures (with the exception of Aortic Aneurysm repair as sole treatment)
  • Acceptable surgical candidate, including use of general anesthesia
  • Willing and able to provide written informed consent
  • Willing and able to return for scheduled follow-up visits

Exclusion Criteria

  • Cardiac valve surgical procedure via conventional full sternotomy
  • Procedures that require a posterolateral thoracotomy
  • Current pregnancy
  • Current use of prescription opioids
  • FEV1 \< 40% predicted
  • Documented myocardial infarction within 30 days of signing Informed Consent Form (ICF)
  • Documented psychiatric disease
  • Documented chronic pain syndrome
  • Documented history of substance abuse
  • Patient currently enrolled in another research study that could directly affect results of either study

Arms & Interventions

Cryoanalgesia + Standard of Care (SOC)

Cryoanalgesia in Conjunction with Standard of Care. Up to 5 sessions of cryoanalgesia for 120 seconds per session.

Intervention: Cryoanalgesia

Cryoanalgesia + Standard of Care (SOC)

Cryoanalgesia in Conjunction with Standard of Care. Up to 5 sessions of cryoanalgesia for 120 seconds per session.

Intervention: Standard of Care

Standard of Care

Institutional SOC for pain management will be followed. The use of local post-operative pain management techniques (i.e., intercostal, peri-vertebral, or any other acceptable method) is permitted for both treatment groups up to 24 hours post-operatively according to institutional standard of care.

Intervention: Standard of Care

Outcomes

Primary Outcomes

Primary Outcome 1: Forced Expiratory Volume (FEV1) at 48-Hours Post-Surgery

Time Frame: 48-hours post-surgery

Forced Expiratory Volume (FEV1) is the measurement of how much air, in volume, that a person can exhale with a forced breath. It is measured using a spirometer device.

Primary Outcome 2: Visual Analogue Scale (VAS) Pain in the Surgical Region at 48-Hours Post-Surgery

Time Frame: 48-hours post-surgery

The Visual Analogue Scale (VAS) uses a picture of a linear scale that shows numbers 0-10 with 0 being the least amount of pain and 10 being the most amount of pain. This outcome looked at pain in the surgical region specifically.

Secondary Outcomes

  • Secondary Outcome 1: Spirometry Assessments at 48-Hours Post-Extubation(48-hours post-extubation)
  • Secondary Outcome 2: Visual Analogue Scale (VAS) Pain at the 72, 96 and 120-Hours Post-Op Time Points(72-, 96- and 120-hours Post-Op)
  • Secondary Outcome 3: Allodynia at the 3 and 6 Month Visit(3 and 6 Months)
  • Secondary Outcome 4: Duration of Oral Endotracheal Intubation From Extubation Until the Patient Leaves the Operating Room(Hours until patient is extubated from time patient leaves the operating room)
  • Secondary Outcome 6: ICU and Hospital Length of Stay From Procedure to Discharge(Procedure to Discharge)
  • Secondary Outcome 7: Ambulatory Movement During Hospital Stay(Baseline, 48, 72, 96, 120 Hours and Discharge)
  • Secondary Outcome 5: Patient Controlled Analgesia (PCA) and Oral Opioid Consumption at the 24, 48, 96 and 120 Hour Time Points(24-, 48, -96 and 120-hours)

Study Sites (5)

Loading locations...

Similar Trials